GSK announced that Luke Miels, the company’s chief commercial officer, will take over as CEO on Jan. 1, replacing Emma ...

GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on ...

Walmsley, who helped push GSK to focus more exclusively on specialty medicines and oncology, will be succeeded by commercial ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Commercial chief Luke Miels will take the helm as the pharma company seeks to bring to replenish its product lineup to offset ...

Most federal departments and agencies have put out guidance about which programs will stay open and which ones won't if ...

Lupin's shares surged by 2.2% following tentative U.S. FDA approval for its generic HIV treatment, Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets. This positions Lupin to enter a ...

GSK plc names new CEO as shares rise 3% and maintains a 4% dividend yield; get key insights on GSK stock's outlook and what ...

Walmsley, who became CEO of the U.K. drugmaker in 2017 and is due to step down at the end of the year, led GSK through the Covid-19 pandemic, a fight with activist investor Elliott Management, and a ...

The US Department of Health and Human Services (HHS) has warned that more than 32,000 of its staff could be furloughed if ...